Cognition Therapeutics INC (CGTX) SEC Filings — 2024
21 SEC filings for Cognition Therapeutics INC (CGTX) in 2024.
Filings
- Cognition Therapeutics Files 8-K — 8-K · Dec 18, 2024
- Cognition Therapeutics Files 8-K on Financials — 8-K · Nov 13, 2024
- Cognition Therapeutics Q3 2024 Update — 10-Q · Nov 13, 2024
- Cognition Therapeutics Files 8-K — 8-K · Oct 1, 2024
- Cognition Therapeutics Faces Delisting Concerns — 8-K · Sep 13, 2024
- Cognition Therapeutics Files 8-K — 8-K · Aug 28, 2024
- Cognition Therapeutics Files 8-K on Financials — 8-K · Aug 8, 2024
- Cognition Therapeutics Q2 2024 10-Q Filed — 10-Q · Aug 8, 2024
- Cognition Therapeutics Files 8-K — 8-K · Jul 29, 2024
- Cognition Therapeutics Files 8-K on Security Holder Votes — 8-K · Jun 7, 2024
- Cognition Therapeutics Files 8-K on Financials — 8-K · May 7, 2024
- Cognition Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Cognition Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Cognition Therapeutics Files 8-K — 8-K · Mar 26, 2024
- Cognition Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
- Cognition Therapeutics Enters Material Definitive Agreement — 8-K · Mar 13, 2024
- Cognition Therapeutics Files 8-K — 8-K · Mar 11, 2024
- Cognition Therapeutics Reports Officer Changes and Compensation Arrangements — 8-K · Feb 20, 2024
- AIGH Capital Management Discloses 5.9% Stake in Cognition Therapeutics — SC 13G/A · Feb 7, 2024
- Pathstone Family Office Discloses 1M Share Stake in Cognition Therapeutics — SC 13G · Jan 19, 2024
- Cognition Therapeutics Files Routine 8-K on Jan 4, 2024 — 8-K · Jan 4, 2024